Seqens Seqens

X

Find the latest news about Kewpie Corporation aggregated by PharmaCompass.com.

  • Webinars & Exhibitions

  • Hyaluronic Acid

  • Sodium Hyaluronate

PharmaCompass
left grey arrow
right gray arrow

https://www.kewpie.com/en/newsrelease/pdf/2024/newsrelease_20240112.pdf

PRESS RELEASE
10 Jan 2024

https://www.kewpie.com/en/ir/pdf/accounts/2023/Summary_of_Consolidated_Financial_Statements_for_the_Third_Quarter_of_the_Fiscal_Year_Ending_November_30_2023.pdf

PRESS RELEASE
05 Oct 2023

https://www.kewpie.com/en/ir/pdf/annual-report/Annual_Report_2022.pdf

PRESS RELEASE
28 Apr 2023

https://www.kewpie.com/en/ir/pdf/accounts/2023/Summary_of_Consolidated_Financial_Statements_for_the_First_Quarter_of_the_Fiscal_Year_Ending_November_30_2023.pdf

PRESS RELEASE
06 Apr 2023

https://www.kewpie.com/en/ir/pdf/briefing/2022/FY2022_Financial_Meeting.pdf

PRESS RELEASE
02 Feb 2023

https://www.kewpie.com/en/ir/pdf/news/2023/Notice_of_Settlement_of_Accounts_of_Parent_Company_Etc.pdf

PRESS RELEASE
20 Jan 2023

https://www.kewpie.com/en/ir/pdf/news/2022/Notice_of_Change_in_Major_Shareholders.pdf

PRESS RELEASE
15 Nov 2022

https://www.kewpie.com/en/ir/pdf/news/2022/A_New_Condiments_Production_Base_in_Tennessee_the_U.S..pdf

PRESS RELEASE
10 Nov 2022

https://www.kewpie.com/en/ir/pdf/accounts/2022/Summary_of_Consolidated_Financial_Statements_for_the_Third_Quarter_of_the_Fiscal_Year_Ending_November_30_2022.pdf

PRESS RELEASE
07 Oct 2022

https://www.kewpie.com/en/ir/pdf/news/2022/Notice_regarding_Revision_of_the_Forecasts_of_Consolidated_Operating_Results_for_the_Fiscal_Year_Ending_November_30_2022.pdf

PRESS RELEASE
07 Jul 2022
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY